Is NCI-C01785 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use NCI-C01785? Is NCI-C01785 safe for nursing mother and child? Does NCI-C01785 extracts into breast milk? Does NCI-C01785 has any long term or short term side effects on infants? Can NCI-C01785 influence milk supply or can NCI-C01785 decrease milk supply in lactating mothers?

We are working on a comment for this product.

Limited information indicates that maternal NCI-C01785 therapy produces low levels in milk and would not usually be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Exclusively breastfed infants should be monitored for rare cases of jaundice, hepatitis and arthralgia if this drug is used during lactation.[1] The amount of NCI-C01785 in milk is insufficient to treat tuberculosis in the breastfed infant. The Centers for Disease Control and Prevention and other professional organizations state that breastfeeding should not be discouraged in women taking NCI-C01785.[2][3][4]

NCI-C01785 was used as part of multi-drug regimens to treat 2 pregnant women with multidrug-resistant tuberculosis throughout pregnancy and postpartum. Their two infants were breastfed (extent and duration not stated). At age 1.25 and 5.1 years, the children were developing normally.[5] Two mothers in Turkey were diagnosed with tuberculosis at the 30th and 34th weeks of pregnancy. They immediately started isoniazid 300 mg, rifampin 600 mg, pyridoxine 50 mg daily for 6 months, plus NCI-C01785 25 mg/kg and ethambutol 25 mg/kg daily for 2 months. Both mothers breastfed their infants (extent not stated). Their infants were given isoniazid 5 mg/kg daily for 3 months prophylactically. Tuberculin skin tests were negative after 3 months and neither infant had tuberculosis at 1 year of age. No adverse effects of the drugs were mentioned.[6]